Advertisement

Document › Details
Kadans Science Partner. (7/24/24). "Press Release: Kadans Science Partner Commences Work on New Purpose-built Wet Lab Facilities at Merlin Place, North Cambridge". Cambridge.
> New facilities adjacent to the Cambridge Science Park will comprise CL2 wet labs, dry labs and office space over six storeys
> Latest ground-up development in Cambridge delivered by Kadans Science Partner to provide the facilities needed by health, life science and technology companies
Kadans Science Partner, a leading investor in the development of ecosystems and real estate with a dedicated focus on knowledge-intensive sectors, today announced that construction work has started at Merlin Place, North Cambridge.
The 139,000 sq ft development, expected to complete in 2026, will feature six storeys of state-of-the-art lab and office space, allowing for full flexibility for a single- or multi-tenant split. It has been designed to become the “Gateway Building for the Cambridge North Cluster”, and a specialist hub for health, life science and technology companies of different sizes.
Throughout the planning process, Kadans has carefully considered the broader Cambridge community, incorporating a public café and communal social spaces into the design of the site. Sustainability has been prioritised, with a dedicated internal cycle storage and cycle maintenance area, as well as end of journey facilities including showers and changing rooms, encouraging alternative commuting options such as cycling and walking.
Companies to be based at Merlin Place will also benefit from the proximity of the Cambridge Science Park and transport links, including Cambridge North Station, guided busway, and expanding cycle routes. Merlin Place is the latest addition to Kadans’ Cambridge portfolio, which also includes a site at the Babraham Research Campus.
Katie Nelson, Head of Leasing UK & Ireland, Kadans Science Partner, said: “As we look to address the current lack of available purpose-built facilities in Cambridge, we are working closely with health, life science and technology companies to understand their specific requirements and provide bespoke laboratory solutions that align. We are very proud to extend our footprint in Cambridge and support the continued growth of the life science sector here, a vital part of the UK ecosystem. Our aim is to provide best in class amenities and the highest quality lab facilities and office spaces. This project is particularly exciting because the location, scale, and specification will position Merlin Place among the best assets in the region.”
ENDS
Notes to Editors
[image] Katie Nelson, Head of Leasing UK & Ireland, Kadans Science Partner
[image] Merlin Place, North Cambridge
For high-resolution images please contact Zyme Communications.
Media Contact:
Lorna Cuddon
Zyme Communications:
Tel: +44 (0)7811 996 942
Email: [email protected]
Katie Nelson
Head of Leasing UK & Ireland, Kadans Science Partner
Tel: +44 (0)7899 103279
Email: [email protected]
About Kadans Science Partner www.kadans.co.uk:
Kadans Science Partner is the European leader investing in the development of ecosystems and real estate with a dedicated focus on knowledge-intensive sectors. We focus on bringing people together to overcome global challenges. Therefore, we invest, develop and operate specialised assets to complement science clusters. Across Europe, we have built a network of clients, partner organisations, and innovative minds, active in Life Sciences & Health, Food, Energy & Digital Economy. All determined to find solutions to the global challenges we face today. Currently already active in 25+ science clusters, our network continues to grow as we develop more locations and support more clusters across Europe.
Instagram: @kadanssciencepartner
Twitter: @KadansScience
Record changed: 2024-08-15 |
Advertisement

More documents for Axa (Group)
- [1] Kadans Science Partner. (1/29/24). "Press Release: Kadans Becomes New Partner for Rheinland-Pfalz Location – Collaboration with Technologiezentrum Mainz"....
- [2] BioInvent International AB. (7/12/22). "Press Release: BioInvent Has Successfully Carried Out a Directed Share Issue of approximately SEK 300 Million (approximately USD 28.3 Million) [ Not for US, AU, et al. ]". Lund....
- [3] AXA Investment Managers. (4/4/22). "Press Release: AXA IM Alts Launches $500 Million Private Equity Healthcare Strategy alongside Two Senior Appointments"....
- [4] Kadans Science Partner. (3/30/22). "Press Release: Europe’s Largest Commercial Lab Building to Be Built at Canary Wharf, London"....
- [5] AXA Investment Managers. (7/26/21). "Press Release: AXA IM Alts Raises €1.9 Billion for European Life Sciences Investments"....
- [6] AXA Investment Managers. (11/26/20). "Press Release: AXA Investment Managers - Real Assets to Enter European Life Science Sector with Acquisition of Kadans Science Partner Platform"....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement

» top